Depression, Anxiety and Stress
Mood and anxiety disorders are prevalent, disabling illnesses that affect more than 1 in 10 individuals during the course of their lifetime. They are among the leading causes of disease burden worldwide.
Mount Sinai offers an extensive range of clinical services for adults, adolescents, and children with mood and anxiety disorders, as well as patients with traumatic stress disorders at:
Expert clinicians specializing in psychopharmacology and a variety of psychotherapeutic modalities offer in both inpatient and outpatient treatment settings. In addition, specialized neuropsychological testing and evaluation is available.
Ongoing groundbreaking research underway at the Mood and Anxiety Disorders Program at The Friedman Brain Institute is yielding novel insights into the causes and pathophysiology of depression, anxiety, and post-traumatic stress disorder, knowledge that is driving discoveries of fundamentally new treatments. Research is also underway into obsessive-compulsive and related disorders. For example, Mount Sinai scientists and physicians have played a leading role in the development of Ketamine as the first rapidly acting antidepressant medication. In addition, at the Center for Neuromodulation, we are exploring the use of deep brain stimulation to treat these disorders.
This research is tightly linked to efforts to understand the neurobiology of depression, anxiety, and traumatic disorders in animal models. Learn more.
Schedule an Appointment
James W. Murrough, MD
1428 Madison Avenue
E Level, Room ABE-39
New York, NY 10029
- Conte Center on Depression
- Depression Patient Care at Mount Sinai
- Mood and Anxiety Disorders Program
- Patient Psychiatric Services
- Pediatric Mood and Anxiety Disorders Program
- Psychiatry Areas of Care
Related Resources Outside of Mount Sinai
- Brain and Behavior Research Foundation
- Depression and Bipolar Support Alliance
- National Alliance on Mental Illness
- National Institute of Mental Health